Fundamental Analysis of APPLIED THERAPEUTICS INC(NASDAQ:APLT) stock

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to APLT. APLT was compared to 571 industry peers in the Biotechnology industry. APLT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. APLT has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

APLT had negative earnings in the past year.

APLT had a negative operating cash flow in the past year.

In the past 5 years APLT always reported negative net income.

In the past 5 years APLT always reported negative operating cash flow.

1.2 Ratios

APLT has a Return On Assets of -252.80%. This is amonst the worse of the industry: APLT underperforms 92.95% of its industry peers.

APLT has a worse Return On Equity (-4572.20%) than 84.13% of its industry peers.

		Industry Rank	Sector Rank
ROA	-252.8%
ROE	-4572.2%
ROIC	N/A

ROA(3y)-183.57%

ROA(5y)-146.93%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

APLT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, APLT has more shares outstanding

Compared to 5 years ago, APLT has more shares outstanding

There is no outstanding debt for APLT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

APLT has an Altman-Z score of -6.22. This is a bad value and indicates that APLT is not financially healthy and even has some risk of bankruptcy.

APLT has a Altman-Z score of -6.22. This is in the lower half of the industry: APLT underperforms 65.96% of its industry peers.

There is no outstanding debt for APLT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-6.22

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

APLT has a Current Ratio of 1.06. This is a normal value and indicates that APLT is financially healthy and should not expect problems in meeting its short term obligations.

The Current ratio of APLT (1.06) is worse than 87.30% of its industry peers.

APLT has a Quick Ratio of 1.06. This is a normal value and indicates that APLT is financially healthy and should not expect problems in meeting its short term obligations.

APLT's Quick ratio of 1.06 is on the low side compared to the rest of the industry. APLT is outperformed by 85.54% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.06
Quick Ratio	1.06

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for APLT have decreased strongly by -24.58% in the last year.

Looking at the last year, APLT shows a decrease in Revenue. The Revenue has decreased by -1.98% in the last year.

EPS 1Y (TTM)-24.58%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-2.13%

Revenue 1Y (TTM)-1.98%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, APLT will show a very strong growth in Earnings Per Share. The EPS will grow by 22.89% on average per year.

The Revenue is expected to grow by 105.26% on average over the next years. This is a very strong growth

EPS Next Y28.34%

EPS Next 2Y28.59%

EPS Next 3Y28.85%

EPS Next 5Y22.89%

Revenue Next Year-83.12%

Revenue Next 2Y134.9%

Revenue Next 3Y138.1%

Revenue Next 5Y105.26%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

APLT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for APLT. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

APLT's earnings are expected to grow with 28.85% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y28.59%

EPS Next 3Y28.85%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

APLT does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

APPLIED THERAPEUTICS INC

NASDAQ:APLT (11/29/2024, 3:17:52 PM)

After market: 2.13 +0.1 (+4.93%)

2.03

-6.54 (-76.31%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap236.21M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-252.8%
ROE	-4572.2%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.1

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	1.06
Quick Ratio	1.06
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-24.58%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y28.34%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-1.98%

Revenue growth 3YN/A

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

APPLIED THERAPEUTICS INC (APLT)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens